drugset / Trial / NCT07611019

Colchicine for the Prevention of Post-Operative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Single-Center, Strategy-Stratified, Randomized, Double-Blind, Placebo-Controlled Trial

NCT07611019

Phase 2/3 Enrolling by invitation 400 enrolled National Taiwan University Hospital
RandomizedParallel-groupTriple-blindPrevention

Summary

Post-operative atrial fibrillation after coronary artery bypass grafting (CABG)

Timeline

Start
2026-07-06
Primary completion
2028-07
Completion
2028-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Colchicine Small molecule 0.5 mg Oral

Indications

No indication recorded.